Purpose of reviewChemotherapy-induced peripheral neurotoxicity (CIPN) is a common and distressing side-effect of many chemotherapy regimens. Currently, aside from symptomatic treatments for neuropathic pain, there are no treatments to prevent CIPN or treat established CIPN. We discuss recent articles addressing clinimetric issues and treatment of CIPN.Recent findingsThere are important clinimetric issues that need to be addressed so that robust clinical trials in CIPN can be performed. There are new compounds in early development that may treat CIPN, but larger studies are needed.SummaryA multidisciplinary, international approach is needed to unravel CIPN; the Toxic Neuropathy Consortium (TNC) of the Peripheral Nerve Society may be the home for such efforts.
- chemotherapy-induced peripheral neurotoxicity
- clinical trials
- clinimetric endpoint
- patient-reported outcome measure
- toxic neuropathy consortium
ASJC Scopus subject areas
- Clinical Neurology